Skip to main content
. 2022 Jan 29;15:65–79. doi: 10.2147/PGPM.S347018

Table 2.

Correlation Between SOCS2 Variants and T2DM Risk

SNPs ID Models Genotype Case Control Adjusted by Age and Gender
OR (95% CI) p
rs3825199 Allele A 646 676 1
G 354 326 1.14 (0.94–1.37) 0.176
Genotype AA 200 237 1
AG 246 202 1.44 (1.11–1.88) 0.007*
GG 54 62 1.03 (0.68–1.56) 0.881
Dominant AG-GG vs AA 1.35 (1.05–1.73) 0.020
Recessive GG vs AA-AG 0.86 (0.58–1.26) 0.437
Log-additive AA+AG+GG 1.14 (0.94–1.37) 0.177
rs11107116 Allele G 653 679 1
T 347 323 1.12 (0.93–1.35) 0.243
Genotype GG 205 238 1
GT 243 203 1.39 (1.07–1.81) 0.014
TT 52 60 1.01 (0.66–1.52) 0.978
Dominant GT-TT vs GG 1.30 (1.01–1.67) 0.038
Recessive TT vs GG-GT 0.85 (0.58–1.27) 0.430
Log-additive GG+GT+TT 1.12 (0.93–1.35) 0.243
rs10492321 Allele T 617 656 1
A 383 346 1.18 (0.98–1.41) 0.080
Genotype TT 183 224 1
TA 251 208 1.48 (1.13–1.93) 0.004*
AA 66 69 1.17 (0.79–1.73) 0.428
Dominant TA-AA vs TT 1.40 (1.09–1.81) 0.009*
Recessive AA vs TT-TA 0.95 (0.66–1.37) 0.791
Log-additive TT+TA+AA 1.18 (0.98–1.41) 0.081

Notes: p values were calculated by logistic regression analysis with adjustments for age and gender. Bold values indicate that p < 0.05 means the data are statistically significant.*p indicates that after Bonferroni correction (p < 0.05/5) means the data are statistically significant.

Abbreviations: SNP, single-nucleotide polymorphism; T2DM, type 2 diabetes mellitus; OR, odds ratio; 95% CI, 95% confidence interval.